Factors affecting the pharmacokinetics, biodistribution and toxicity of gold nanoparticles in drug delivery

Current Drug Metabolism

Volumn 17, Issue 9, 2016, Pages 849-861

  Xia, Qiyue ^a   Li, Hongxia ^a   Xiao, Kai ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Biodistribution; Blood brain barrier; Drug delivery; Gold nanoparticles; Pharmacokinetics; Physicochemical properties; Toxicity

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GOLD NANOPARTICLE; REACTIVE OXYGEN METABOLITE; GOLD; METAL NANOPARTICLE;

ANTINEOPLASTIC ACTIVITY; BIOACCUMULATION; BIOCOMPATIBILITY; BIOLOGICAL ACTIVITY; BLOOD BRAIN BARRIER; CELL VIABILITY; CYTOTOXICITY; DNA DAMAGE; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG COATING; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG PENETRATION; DRUG RETENTION; DRUG STABILITY; HUMAN; MITOPHAGY; NONHUMAN; PERMEABILITY BARRIER; PHOTOTHERMAL THERAPY; PHOTOTOXICITY; PHYSICAL CHEMISTRY; RENAL CLEARANCE; REVIEW; TISSUE DISTRIBUTION; URINARY EXCRETION; ANIMAL;

ANIMALS; GOLD; HUMANS; METAL NANOPARTICLES; TISSUE DISTRIBUTION;

EID: 84996588069     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/1389200217666160629114941     Document Type: Review

References (73)

1. Lajunen, T.; Viitala, L.; Kontturi, L.S.; Laaksonen, T.; Liang, H.; Vuorimaa-Laukkanen, E.; Viitala, T.; Le Guevel, X.; Yliperttula, M.; Murtomaki, L.; Urtti, A. Light induced cytosolic drug delivery from liposomes with gold nanoparticles. J. Control. Release, 2015, 203, 85-98.
2. Muddineti, O.S.; Ghosh, B.; Biswas, S. Current trends in using polymer coated gold nanoparticles for cancer therapy. Int. J. Pharm., 2015, 484(1-2), 252-267.
3. Veiseh, O.; Gunn, J.W.; Zhang, M. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv. Drug Deliv. Rev., 2010, 62(3), 284-304.
4. Wang, L.; Liu, Y.; Li, W.; Jiang, X.; Ji, Y.; Wu, X.; Xu, L.; Qiu, Y.; Zhao, K.; Wei, T.; Li, Y.; Zhao, Y.; Chen, C. Selective targeting of gold nanorods at the mitochondria of cancer cells: Implications for cancer therapy. Nano. Lett., 2011, 11(2), 772-780.
5. Patra, C.R.; Bhattacharya, R.; Wang, E.; Katarya, A.; Lau, J.S.; Dutta, S.; Muders, M.; Wang, S.; Buhrow, S.A.; Safgren, S.L.; Yaszemski, M.J.; Reid, J.M.; Ames, M.M.; Mukherjee, P.; Mukhopadhyay, D. Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. Cancer Res., 2008, 68(6), 1970-1978.
6. Libutti, S. K.; Paciotti, G. F. ; Myer, L.; Haynes, R.; Gannon, W.; Walker, M.; Seidel, G.; Byrnes, A.; Yuldasheva, N.; Tamarkin, L. Results of a completed phase I clinical trial of CYT-6091: A pegylated colloidal gold-TNF. Nanomedicine, 2009, 27, 3586.
7. El-Sayed, I.H. Nanotechnology in head and neck cancer: The race is on. Curr. Oncol. Rep., 2010, 12(2), 121-128.
8. Kennedy, L.C.; Bickford, L.R.; Lewinski, N.A.; Coughlin, A.J.; Hu, Y.; Day, E.S.; West, J.L.; Drezek, R.A. A new era for cancer treatment: Gold-nanoparticle-mediated thermal therapies. Small, 2011, 7(2), 169-183.
9. Bednarski, M.; Dudek, M.; Knutelska, J.; Nowiski, L.; Sapa, J.; Zygmunt, M.; Nowak, G.; Luty-Bocho, M.; Wojnicki, M.; Fitzner, K.; Tsiorowski, M. The influence of the route of administration of gold nanoparticles on their tissue distribution and basic biochemical parameters: In vivo studies. Pharmacol. Rep., 2015, 67(3), 405-409.
10. Wojnicki, M.; Luty-Bocho, M.; Bednarski, M.; Dudek, M.; Knutelska, J.; Sapa, J.; Zygmunt, M.; Nowak, G.; Fitzner, K. Tissue distribution of gold nanoparticles after single intravenous administration in mice. Pharmacol. Rep., 2013, 65(4), 1033-1038.
11. Balasubramanian, S.K.; Jittiwat, J.; Manikandan, J.; Ong, C.N.; Yu, L.E.; Ong, W.Y. Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats. Biomaterials, 2010, 31(8), 2034-2042.
12. Lipka, J.; Semmler-Behnke, M.; Sperling, R.A.; Wenk, A.; Takenaka, S.; Schleh, C.; Kissel, T.; Parak, W.J.; Kreyling, W.G. Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials, 2010, 31(25), 6574-6581.
13. Lasagna-Reeves, C.; Gonzalez-Romero, D.; Barria, M.A.; Olmedo, I.; Clos, A.; Sadagopa Ramanujam, V.M.; Urayama, A.; Vergara, L.; Kogan, M.J.; Soto, C. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem. Biophys. Res. Commun., 2010, 393(4), 649-655.
14. Khlebtsov, N.; Dykman, L. Biodistribution and toxicity of engineered gold nanoparticles: A review of in vitro and in vivo studies. Chem. Soc. Rev., 2011, 40(3), 1647-1671.
15. Puvanakrishnan, P.; Park, J.; Chatterjee, D.; Krishnan, S.; Tunnell, J.W. In vivo tumor targeting of gold nanoparticles: Effect of particle type and dosing strategy. Int. J. Nanomed., 2012, 7, 1251-1258.
16. Arnida; Janat-Amsbury, M.M.; Ray, A.; Peterson, C.M.; Ghandehari, H. Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Eur. J. Pharm. Biopharm., 2011, 77(3), 417-423.
17. Wang, L.; Li, Y.F.; Zhou, L.; Liu, Y.; Meng, L.; Zhang, K.; Wu, X.; Zhang, L.; Li, B.; Chen, C. Characterization of gold nanorods in vivo by integrated analytical techniques: Their uptake, retention, and chemical forms. Anal. Bioanal. Chem., 2010, 396(3), 1105-1114.
18. Chauhan, V.P.; Popovic, Z.; Chen, O.; Cui, J.; Fukumura, D.; Bawendi, M.G.; Jain, R.K. Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration. Angew. Chem. Int. Ed. Engl., 2011, 50(48), 11417-11420.
19. Krystek, P. A review on approaches to bio distribution studies about gold and silver engineered nanoparticles by inductively coupled plasma mass spectrometry. Microchem. J., 2012, 105, 39-43.
20. Hirn, S.; Semmler-Behnke, M.; Schleh, C.; Wenk, A.; Lipka, J.; Schaffler, M.; Takenaka, S.; Moller, W.; Schmid, G.; Simon, U.; Kreyling, W.G. Particle size-dependent and surface chargedependent biodistribution of gold nanoparticles after intravenous administration. Eur. J. Pharm. Biopharm., 2011, 77(3), 407-416.
21. Cho, W.S.; Cho, M.; Jeong, J.; Choi, M.; Han, B.S.; Shin, H.S.; Hong, J.; Chung, B.H.; Jeong, J.; Cho, M.H. Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxicol. Appl. Pharmacol., 2010, 245(1), 116-123.
22. Huang, K.; Ma, H.; Liu, J.; Huo, S.; Kumar, A.; Wei, T.; Zhang, X.; Jin, S.; Gan, Y.; Wang, P.C.; He, S.; Zhang, X.; Liang, XJ. Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, Multicellular Spheroids, and Tumors in vivo. ACSNANO, 2012, 6(5), 4483-4493.
23. Oh, E.; Delehanty, J.B.; Sapsfordm K.E.; Susumu, K.; Goswami, R.; Blanco-Canosa, J.B.; Dawson, P.E.; Granek, J.; Shoff, M.; Zhang, Q.; Goering, P.L.; Huston, A.; Medintz, I.L. Cellular uptake and fate of PEgylated gold nanoparticles is dependent on both cellpenetration peptides and particle size. ASCNANO, 2011, 5(8), 6434-6448
24. Cabral, H.; Matsumoto, Y.; Mizuno, K.; Chen, Q.; Murakami, M.; Kimura, M.; Terada, Y.; Kano, M.R.; Miyazono, K.; Uesaka, M.; Nishiyama, N.; Kataoka, K. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat. Nanotechnol., 2011, 6(12), 815-823.
25. Balogh, L.; Nigavekar, S.S.; Nair, B.M.; Lesniak, W.; Zhang, C.; Sung, L.Y.; Kariapper, M.S.; El-Jawahri, A.; Llanes, M.; Bolton, B.; Mamou, F.; Tan, W.; Hutson, A.; Minc, L.; Khan, M.K. Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models. Nanomedicine, 2007, 3(4), 281-296.
26. Kim, B.; Han, G.; Toley, B.J.; Kim, C.K.; Rotello, V.M.; Forbes, N.S. Tuning payload delivery in tumour cylindroids using gold nanoparticles. Nat. Nanotechnol., 2010, 5(6), 465-472.
27. Qiu, Y.; Liu, Y.; Wang, L.; Xu, L.; Bai, R.; Ji, Y.; Wu, X.; Zhao, Y.; Li, Y.; Chen, C. Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials, 2010, 31(30), 7606-7619.
28. Zhang, X.D.; Wu, D.; Shen, X.; Liu, P.X.; Fan, F.Y.; Fan, S.J. In vivo renal clearance, biodistribution, toxicity of gold nanoclusters. Biomaterials, 2012, 33(18), 4628-4638.
29. Huang, X.; Peng, X.; Wang, Y.; Wang, Y.; Shin, D.M.; El-Sayed, M.A.; Nie, S. ElSayed, Shuming, N. A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano, 2010, 4 (2010), 5887-5596.
30. Kievit, F.M.; Zhang, M. Cancer nanotheranostics: Improving imaging and therapy by targeted delivery across biological barriers. Adv. Mater., 2011, 23(36), H217-247.
31. Nielsen, P.A.; Andersson, O.; Hansen, S.H.; Simonsen, K.B.; Andersson, G. Models for predicting blood-brain barrier permeation. Drug Discov. Today, 2011, 16(11-12), 472-475.
32. Guerrero, S.; Araya, E.; Fiedler, J.L.; Arias, J.I.; Adura, C.; Albericio, F.; Giralt, E.; Arias, J.L.; Fernández, M.S.; Kogan, M.J. Improving the brain delivery of gold nanoparticles by conjugation with an amphipathic peptide. Nanomedicine, 2010, 5(6), 897-913.
33. Prades, R.; Guerrero, S.; Araya, E.; Molina, C.; Salas, E.; Zurita, E.; Selva, J.; Egea, G.; Lopez-Iglesias, C.; Teixido, M.; Kogan, M.J.; Giralt, E. Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor. Biomaterials, 2012, 33(29), 7194-7205.
34. Etame, A.B.; Smith, C.A.; Chan, W.C.; Rutka, J.T. Design and potential application of PEGylated gold nanoparticles with sizedependent permeation through brain microvasculature. Nanomedicine, 2011, 7(6), 992-1000.
35. Dixit, S.; Novak, T.; Miller, K.; Zhu, Y.; Kenney, M.E.; Broome, A.M. Transferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumors. Nanoscale, 2015, 7(5), 1782-1790.
36. Zhou, C.; Long, M.; Qin, Y.; Sun, X.; Zheng, J. Luminescent gold nanoparticles with efficient renal clearance. Angew. Chem. Int. Ed. Engl., 2011, 50(14), 3168-3172.
37. Sun, I.C.; Lee, S.; Koo, H.; Kwon, I.C.; Choi, K.; Ahn, C.H.; Kim, K. Caspase sensitive gold nanoparticle for apoptosis imaging in live cells. Bioconjug. Chem., 2010, 21, 1939-1942.
38. Jenkins, J.T.; Halaney, D.L.; Sokolov, K.V.; Ma, L.L.; Shipley, H.J.; Mahajan, S.; Louden, C.L.; Asmis, R.; Milner, T.E.; Johnston, K.P.; Feldman, M.D. Excretion and toxicity of gold-iron nanoparticles. Nanomedicine, 2013, 9(3), 356-365.
39. Simpson, C.A.; Salleng, K.J.; Cliffel, D.E.; Feldheim, D.L. In vivo toxicity, biodistribution, and clearance of glutathione-coated gold nanoparticles. Nanomedicine, 2013, 9(2), 257-263.
40. Park, N.O.J.-H. Surface chemistry of gold nanoparticles mediates their exocytosis in macrophages. ASCNANO, 2014, 8(6), 6232-6241.
41. Kreyling, W.G.; Abdelmonem, A.M.; Ali, Z.; Alves, F.; Geiser, M.; Haberl, N.; Hartmann, R.; Hirn, S.; de Aberasturi, D.J.; Kantner, K.; Khadem-Saba, G.; Montenegro, J.M.; Rejman, J.; Rojo, T.; de Larramendi, I.R.; Ufartes, R.; Wenk, A.; Parak, W.J. In vivo integrity of polymer-coated gold nanoparticles. Nat. Nanotechnol., 2015, 10(7), 619-623.
42. Coradeghini, R.; Gioria, S.; Garcia, C.P.; Nativo, P.; Franchini, F.; Gilliland, D.; Ponti, J.; Rossi, F. Size-dependent toxicity and cell interaction mechanisms of gold nanoparticles on mouse fibroblasts. Toxicol. Lett., 2013, 217(3), 205-216.
43. Xia, W.; Song, H.M.; Wei, Q.; Wei, A. Differential response of macrophages to core-shell Fe3O4@Au nanoparticles and nanostars. Nanoscale, 2012, 4(22), 7143-7148.
44. Liu, Z.; Li, W.; Wang, F.; Sun, C.; Wang, L.; Wang, J.; Sun, F. Enhancement of lipopolysaccharide-induced nitric oxide and interleukin- 6 production by PEGylated gold nanoparticles in RAW264.7 cells. Nanoscale, 2012, 4(22), 7135-7142.
45. Ma, J.S.; Kim, W.J.; Kim, J.J.; Kim, T.J.; Ye, S.K.; Song, M.D.; Kang, H.; Kim, D.W.; Moon, W.K.; Lee, K.H. Gold nanoparticles attenuate LPS-induced NO production through the inhibition of NF-kappaB and IFN-beta/STAT1 pathways in RAW264.7 cells. Nitric Oxide, 2010, 23(3), 214-219.
46. Goodman, C.M.; McCusker, C.D.; Yilmaz, T.; Rotello, V.M. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug. Chem., 2004, 15, 897-900.
47. Schaeublin, N.M.; Braydich-Stolle, L.K.; Schrand, A.M.; Miller, J.M.; Hutchison, J.; Schlager, J.J.; Hussain, S.M. Surface charge of gold nanoparticles mediates mechanism of toxicity. Nanoscale, 2011, 3(2), 410-420.
48. Chuang, S.M.; Lee, Y.H.; Liang, R.Y.; Roam, G.D.; Zeng, Z.M.; Tu, H.F.; Wang, S.K.; Chueh, P.J. Extensive evaluations of the cytotoxic effects of gold nanoparticles. Biochim. Biophys. Acta, 2013, 1830(10), 4960-4973.
49. Cui, L.; Zahedi, P.; Saraceno, J.; Bristow, R.; Jaffray, D.; Allen, C. Neoplastic cell response to tiopronin-coated gold nanoparticles. Nanomedicine, 2013, 9(2), 264-273.
50. Paino, I.M.; Marangoni, V.S.; de Oliveira Rde, C.; Antunes, L.M.; Zucolotto, V. Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells. Toxicol. Lett., 2012, 215(2), 119-125.
51. Coulter, J.A.; Jain, S.; Butterworth, K.T.; Taggart, L.E.; Dickson, G.R.; McMahon, S.J.; Hyland, W.B.; Muir, M.F.; Trainor, C.; Hounsell, A.R.; O'Sullivan, J.M.; Schettino, G.; Currell, F.J.; Hirst, D.G.; Prise, K.M. Cell type-dependent uptake, localization, and cytotoxicity of 1.9 nm gold nanoparticles. Int. J. Nanomed., 2012, 7, 2673-2685.
52. Fytianos, K.; Rodriguez-Lorenzo, L.; Clift, M.J.; Blank, F.; Vanhecke, D.; von Garnier, C.; Petri-Fink, A.; Rothen-Rutishauser, B. Uptake efficiency of surface modified gold nanoparticles does not correlate with functional changes and cytokine secretion in human dendritic cells in vitro. Nanomedicine, 2015, 11(3), 633-644.
53. Sabella, S.; Carney, R.P.; Brunetti, V.; Malvindi, M.A.; Al-Juffali, N.; Vecchio, G.; Janes, S.M.; Bakr, O.M.; Cingolani, R.; Stellacci, F.; Pompa, P.P. A general mechanism for intracellular toxicity of metal-containing nanoparticles. Nanoscale, 2014, 6(12), 7052-7061.
54. Hwang, J.H.; Kim, S.J.; Kim, Y.H.; Noh, J.R.; Gang, G.T.; Chung, B.H.; Song, N.W.; Lee, C.H. Susceptibility to gold nanoparticleinduced hepatotoxicity is enhanced in a mouse model of nonalcoholic steatohepatitis. Toxicology, 2012, 294(1), 27-35.
55. Fraga, S.; Brandao, A.; Soares, M.E.; Morais, T.; Duarte, J.A.; Pereira, L.; Soares, L.; Neves, C.; Pereira, E.; Bastos Mde, L.; Carmo, H. Short- And long-term distribution and toxicity of gold nanoparticles in the rat after a single-dose intravenous administration. Nanomedicine, 2014, 10(8), 1757-1766.
56. Cho, W.S.; Cho, M.; Jeong, J.; Choi, M.; Cho, H.Y.; Han, B.S.; Kim, S.H.; Kim, H.O.; Lim, Y.T.; Chung, B.H.; Jeong, J. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol. Appl. Pharmacol., 2009, 236(1), 16-24.
57. Gosens, I.; Post, J.A.; de la Fonteyne, L.J.J.; Jansen, E.H.J.M.; Geus, J.W.; Cassee, F.R.; De Jong, W.H. Impact of agglomeration state of nano- And submicron sized gold particles on pulmonary inflammation. Part. Fibre Toxicol., 2010, 7(1), 37.
58. Cardoso, E.; Rezin, G.T.; Zanoni, E.T.; de Souza Notoya, F.; Leffa, D.D.; Damiani, A.P.; Daumann, F.; Rodriguez, J.C.O.; Benavides, R.; Da Silva, L.; Andrade, V.M.; da Silva Paula, M.M. Acute and chronic administration of gold nanoparticles cause DNA damage in the cerebral cortex of adult rats. Mutat. Res., 2014, 766-767, 25-30.
59. Schulz, M.; Ma-Hock, L.; Brill, S.; Strauss, V.; Treumann, S.; Groters, S.; Van Ravenzwaay, B.; Landsiedel, R. Investigation on the genotoxicity of different sizes of gold nanoparticles administered to the lungs of rats. Mutat. Res., 2012, 745(1-2), 51-57.
60. Duncan, B.; Kim, C.; Rotello, V.M. Gold nanoparticle platforms as drug and biomacromolecule delivery systems. J. Control. Release, 2010, 148(1), 122-127.
61. Wang, M.; Thanou, M. Targeting nanoparticles to cancer. Pharmacol. Res., 2010, 62(2), 90-99.
62. Libutti, S.K.; Paciotti, G.F.; Byrnes, A.A.; Alexander, H.R., Jr.; Gannon, W.E.; Walker, M.; Seidel, G.D.; Yuldasheva, N.; Tamarkin, L. Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clin. Cancer Res., 2010, 16(24), 6139-6149.
63. Wang, C.-H.; Liu, C.-J.; Chien, C.-C.; Chen, H.-T.; Hua, T.-E.; Leng, W.-H.; Chen, H.-H.; Kempson, I.M.; Hwu, Y.; Hsiao, M.; Lai, T.-C.; Wang, J.L.; Yang, C.-S.; Lin, H.-M.; Chen, Y.-J.; Margaritondo, G. X-ray synthesized PEGylated (polyethylene glycol coated) gold nanoparticles in mice strongly accumulate in tumors. Mat. Chem. Phys., 2011, 126(1-2), 352-356.
64. Morais, T.; Soares, M.E.; Duarte, J.A.; Soares, L.; Maia, S.; Gomes, P.; Pereira, E.; Fraga, S.; Carmo, H.; Bastos Mde, L. Effect of surface coating on the biodistribution profile of gold nanoparticles in the rat. Eur. J. Pharm. Biopharm., 2012, 80(1), 185-193.
65. Guerrero, S.; Araya, E.; Fiedler, J.L.; Arias, J.I.; Adura, C.; Albericio, F.; Giralt, E.; Arias, J.L.; Fernández, M.S.; Kogan, M.J. Improving the brain delivery of gold nanoparticles by conjugation with an amphipathic peptide. Nanomedicine, 2010, 5(6), 897-913.
66. Ruan, S.; Yuan, M.; Zhang, L.; Hu, G.; Chen, J.; Cun, X.; Zhang, Q.; Yang, Y.; He, Q.; Gao, H. Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles. Biomaterials, 2015, 37, 425-435.
67. Sonavane, G.; Tomoda, K.; Makino, K. Biodistribution of colloidal gold nanoparticles after intravenous administration: Effect of particle size. Colloids Surf. B Biointerf., 2008, 66(2), 274-280.
68. Freese, C.; Uboldi, C.; Gibson, M.I.; Unger, R.E.; Weksler, B.B.; Romero, I.A.; Couraud, P.O.; Kirkpatrick, C.J. Uptake and cytotoxicity of citrate-coated gold nanospheres: Comparative studies on human endothelial and epithelial cells. Part. Fibre Toxicol., 2012, 9, 23.
69. Fede, C.; Fortunati, I.; Weber, V.; Rossetto, N.; Bertasi, F.; Petrelli, L.; Guidolin, D.; Signorini, R.; De Caro, R.; Albertin, G.; Ferrante, C. Evaluation of gold nanoparticles toxicity towards human endothelial cells under static and flow conditions. Microvasc. Res., 2015, 97, 147-155.
70. Jeyaraj, M.; Arun, R.; Sathishkumar, G.; MubarakAli, D.; Rajesh, M.; Sivanandhan, G.; Kapildev, G.; Manickavasagam, M.; Thajuddin, N.; Ganapathi, A. An evidence on G2/M arrest, DNA damage and caspase mediated apoptotic effect of biosynthesized gold nanoparticles on human cervical carcinoma cells (HeLa). Mat. Res. Bullet., 2014, 52, 15-24.
71. Zhang, X.D.; Wu, D.; Shen, X.; Liu, P.X.; Yang, N.; Zhao, B.; Zhang, H.; Sun, Y.M.; Zhang, L.A.; Fan, F.Y. Size-dependent in vivo toxicity of PEG-coated gold nanoparticles. Int. J. Nanomed., 2011, 6, 2071-2081.
72. Balansky, R.; Longobardi, M.; Ganchev, G.; Iltcheva, M.; Nedyalkov, N.; Atanasov, P.; Toshkova, R.; De Flora, S.; Izzotti, A. Transplacental clastogenic and epigenetic effects of gold nanoparticles in mice. Mutat. Res., 2013, 751-752, 42-48.
73. Zhang, X.D.; Wu, H.Y.; Wu, D.; Wang, Y.Y.; Chang, J.H.; Zhai, Z.B.; Meng, A.M.; Liu, P.X.; Zhang, L.A.; Fan, F.Y. Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int. J. Nanomed., 2010, 5, 771-781.